145 related articles for article (PubMed ID: 10588858)
1. Peri-operative care in patients treated for testicular cancer.
Donat SM
Semin Surg Oncol; 1999 Dec; 17(4):282-8. PubMed ID: 10588858
[TBL] [Abstract][Full Text] [Related]
2. Improved management of abdominal undescended testicular tumors with bulky confluent retroperitoneal nodal metastases.
Kulkarni JN; Desai SM; Phadke GK; Tongaonkar HB
J Urol; 1996 Oct; 156(4):1341-4. PubMed ID: 8808867
[TBL] [Abstract][Full Text] [Related]
3. Results of postchemotherapy adjunctive retroperitoneal lymph node dissection in non-seminomatous germ cell cancer patients.
Goepel M; Recker F; Otto T; Krege S; Rübben H
Urol Int; 1996; 57(4):209-12. PubMed ID: 8961487
[TBL] [Abstract][Full Text] [Related]
4. Retroperitoneal lymph node dissection as adjuvant therapy in the treatment of non-seminomatous testicular cancer.
Thijssens K; Vaneerdeweg W; Schrijvers D; Eyskens E; Van Oosterom A
Acta Chir Belg; 2003; 103(6):599-602. PubMed ID: 14743567
[TBL] [Abstract][Full Text] [Related]
5. [Testicular tumor--retroperitoneal lymph node excision successful in patients with stage I nonseminomatous cancer with or without vascular invasion].
Brudermanns B
Aktuelle Urol; 2007 Jan; 38(1):1-2. PubMed ID: 17290323
[No Abstract] [Full Text] [Related]
6. Complications of retroperitoneal lymph node dissection in testicular cancer: primary and post-chemotherapy.
Baniel J; Sella A
Semin Surg Oncol; 1999 Dec; 17(4):263-7. PubMed ID: 10588855
[TBL] [Abstract][Full Text] [Related]
7. Reoperative retroperitoneal surgery for nonseminomatous germ cell tumor: clinical presentation, patterns of recurrence, and outcome.
McKiernan JM; Motzer RJ; Bajorin DF; Bacik J; Bosl GJ; Sheinfeld J
Urology; 2003 Oct; 62(4):732-6. PubMed ID: 14550453
[TBL] [Abstract][Full Text] [Related]
8. Is modified retroperitoneal lymph node dissection (MRLND) still feasible in the treatment of patients with clinical stage I non-seminomatous testicular cancer?
Sosnowski M; Jeromin L; Płuzańska A
Int Urol Nephrol; 1994; 26(4):471-7. PubMed ID: 7528180
[TBL] [Abstract][Full Text] [Related]
9. [Significance pf retroperitoneal lymphadenectomy in the treatment of disseminated germinogenic testicular tumors after induction chemotherapy].
Mitin AV; Figurin KM; Matveev BP; Tiuliandin SA; Bukharin BV; Volkova MI; Matveev VB
Urologiia; 2000; (6):12-6. PubMed ID: 11186312
[No Abstract] [Full Text] [Related]
10. Survival of patients with viable malignant non-seminomatous germ cell tumour persistent after cisplatin-based induction chemotherapy.
Hollender A; Stenwig EA; Ous S; Fosså SD
Eur Urol; 1997; 31(2):141-7. PubMed ID: 9076455
[TBL] [Abstract][Full Text] [Related]
11. Post-chemotherapy residual mass in non-seminomatous testicular cancer. The role of retroperitoneal lymph node dissection.
El Sayed S; Grando JP; Almeida SH; Mortati Neto N; Moreira HA
Int Braz J Urol; 2004; 30(5):384-8. PubMed ID: 15610570
[TBL] [Abstract][Full Text] [Related]
12. Is there a limit for the laparoscopic approach of a retroperitoneal residual mass postchemotherapy?
Gaya JM; Palou J; Peña JA; Rosales A; Maroto P; Sullivan I; Villavicencio H
Actas Urol Esp; 2015 May; 39(4):264-7. PubMed ID: 25619795
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
[TBL] [Abstract][Full Text] [Related]
14. Surgery for testicular cancer: indication, results and technical aspects.
Khouni H; Ghozzi S; Ramzi K; Smaali CH; Majed H; Ben Rais N
Tunis Med; 2005 Dec; 83 Suppl 12():78-83. PubMed ID: 16430075
[TBL] [Abstract][Full Text] [Related]
15. Teratoma in primary testis tumor reduces complete response rates in the retroperitoneum after primary chemotherapy. The case for primary retroperitoneal lymph node dissection of stage IIb germ cell tumors with teratomatous elements.
Rabbani F; Gleave ME; Coppin CM; Murray N; Sullivan LD
Cancer; 1996 Aug; 78(3):480-6. PubMed ID: 8697394
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous retroperitoneal, thoracic, and cervical resection of postchemotherapy residual masses in patients with metastatic nonseminomatous germ cell tumors of the testis.
Brenner PC; Herr HW; Morse MJ; Sheinfeld J; Aprikian A; Bosl GJ; Motzer RJ; Bajorin DF; Schantz S; Fair WR; Burt M
J Clin Oncol; 1996 Jun; 14(6):1765-9. PubMed ID: 8656244
[TBL] [Abstract][Full Text] [Related]
17. Delayed orchiectomy after chemotherapy in patients with advanced testicular cancer.
Ondrus D; Hornák M; Breza J; Mat'oska J; Schnorrer M; Belan V; Kausitz J
Int Urol Nephrol; 2001; 32(4):665-7. PubMed ID: 11989561
[TBL] [Abstract][Full Text] [Related]
18. Integration of surgery and systemic therapy: results and principles of integration.
Donohue JP; Leviovitch I; Foster RS; Baniel J; Tognoni P
Semin Urol Oncol; 1998 May; 16(2):65-71. PubMed ID: 9649229
[TBL] [Abstract][Full Text] [Related]
19. Persistent cancer in postchemotherapy retroperitoneal lymph-node dissection: outcome analysis.
Donohue JP; Fox EP; Williams SD; Loehrer PJ; Ulbright TM; Einhorn LH; Weathers TD
World J Urol; 1994; 12(4):190-5. PubMed ID: 7820140
[TBL] [Abstract][Full Text] [Related]
20. Complications of post-chemotherapy retroperitoneal lymph node dissection.
Baniel J; Foster RS; Rowland RG; Bihrle R; Donohue JP
J Urol; 1995 Mar; 153(3 Pt 2):976-80. PubMed ID: 7853586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
